Chester County News and Community Website
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced the recent nomination of its first development candidate under a collaboration with Moderna, Inc. This candidate is an in vivo …
Carisma Therapeutics and Moderna Nominate New Cancer Therapy Candidate Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its innovative cancer treatment, CT-0525. This therapy targets …
FDA Grants Fast Track Status to Carisma Therapeutics’ New Cancer Therapy Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced a significant milestone in cancer treatment. The company recently dosed the first patient in its Phase 1 clinical trial of …
Carisma Therapeutics Launches First Human Trial for CAR-Monocyte Therapy Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM), a pioneering firm in the field of cancer treatment, has unveiled a series of strategic changes alongside its financial results for the …
Carisma Therapeutics Announces Restructuring and Pipeline Reprioritization Amid Quarterly Financial Report Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM), a pioneering biotechnology firm, has unveiled promising preclinical data for an innovative treatment approach to liver fibrosis, a condition currently posing significant …
Carisma Therapeutics Showcases Breakthrough in Liver and Lung Fibrosis Treatment Read More PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has named Eugene P. Kennedy, M.D., F.A.C.S., as its new Chief Medical Officer. Dr. Kennedy, an esteemed oncologist with over 15 years …
Carisma Therapeutics Appoints Renowned Oncologist as Chief Medical Officer Read More